Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?
- 31 March 1984
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 76 (3) , 450-457
- https://doi.org/10.1016/0002-9343(84)90664-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopeniaThe American Journal of Medicine, 1982
- Duration of empiric antibiotic therapy in granulocytopenic patients with cancerThe American Journal of Medicine, 1979
- Three Antibiotic Regimens in the Treatment of Infection in Febrile Granulocytopenic Patients with CancerThe Journal of Infectious Diseases, 1978
- Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patientsThe American Journal of Medicine, 1977
- The relationship of fever, granulocytopenia and antimicrobial therapy to bacteremia in cancer patientsCancer, 1977
- Fever, neutropenia and malignancy: A clinical syndrome in evolutionCancer, 1977
- A study of antibiotic therapy in fever of unknown origin in neutropenic cancer patientsMedical and Pediatric Oncology, 1977
- Management of fever of unknown origin in patients with neoplasms and neutropeniaCancer, 1973
- Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and GranulocytopeniaNew England Journal of Medicine, 1971
- THE SPECTRUM OF THE DISEASE IN 98 PATIENTSMedicine, 1970